Travere Therapeutics (TVTX) Acquisitions (2014 - 2016)

Travere Therapeutics (TVTX) has 3 years of Acquisitions data on file, last reported at $115000.0 in Q4 2016.

• Quarterly Acquisitions changed N/A year-over-year to $115000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2017 was $115000.0 (down 81.3% YoY) and the FY2020 annual result came in at $95.3 million, changed N/A from the prior year.
• Acquisitions slipped to $115000.0 in Q4 2016, from $500000.0 in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $33.4 million in Q1 2015 to a low of $115000.0 in Q4 2016.
• A 3-year average of $15.8 million and a median of $14.8 million in 2014 frame the typical range for Acquisitions.
• The widest YoY moves for Acquisitions: up 14.68% in 2015, down 14.68% in 2015.
• Tracing TVTX's Acquisitions over 3 years: stood at $29.2 million in 2014, then gained by 14.68% to $33.4 million in 2015, then sank by 99.66% to $115000.0 in 2016.
• The last three Acquisitions figures came in at $115000.0 (Q4 2016), $500000.0 (Q2 2016), and $33.4 million (Q1 2015), per Business Quant data.